↓ Skip to main content

Suppression of the Inflammatory Cascade is Implicated in Resveratrol Chemoprevention of Experimental Hepatocarcinogenesis

Overview of attention for article published in Pharmaceutical Research, April 2010
Altmetric Badge

Mentioned by

peer_reviews
1 peer review site

Citations

dimensions_citation
69 Dimensions

Readers on

mendeley
39 Mendeley
Title
Suppression of the Inflammatory Cascade is Implicated in Resveratrol Chemoprevention of Experimental Hepatocarcinogenesis
Published in
Pharmaceutical Research, April 2010
DOI 10.1007/s11095-010-0144-4
Pubmed ID
Authors

Anupam Bishayee, Abhijeet Waghray, Kendra F. Barnes, Thomas Mbimba, Deepak Bhatia, Malay Chatterjee, Altaf S. Darvesh

Abstract

Resveratrol, present in grapes and red wine, has been found to prevent diethylnitrosamine (DENA)-initiated rat liver tumorigenesis, though the chemopreventive mechanisms are not completely elucidated. The current study was designed to explore whether the antiinflammatory properties of resveratrol play a role in its antihepatocarcinogenic action.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Russia 1 3%
Portugal 1 3%
Germany 1 3%
Unknown 36 92%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 18%
Student > Master 6 15%
Researcher 5 13%
Student > Bachelor 4 10%
Student > Postgraduate 3 8%
Other 7 18%
Unknown 7 18%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 23%
Medicine and Dentistry 8 21%
Chemistry 4 10%
Pharmacology, Toxicology and Pharmaceutical Science 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Other 7 18%
Unknown 6 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2014.
All research outputs
#15,303,056
of 22,758,963 outputs
Outputs from Pharmaceutical Research
#2,232
of 2,855 outputs
Outputs of similar age
#77,393
of 95,049 outputs
Outputs of similar age from Pharmaceutical Research
#43
of 49 outputs
Altmetric has tracked 22,758,963 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,855 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one is in the 14th percentile – i.e., 14% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 95,049 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 49 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.